| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/30/1994 | US5342977 Aminosulfonic acid derivatives and processes for their preparation |
| 08/30/1994 | US5342838 Phenolic thioetheramides |
| 08/30/1994 | US5342620 Use of borate-polyol complexes in ophthalmic compositions |
| 08/30/1994 | US5342615 Method for treating arthritis or inflammation with Il-1α or derivatives thereof |
| 08/30/1994 | CA1331757C 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| 08/24/1994 | EP0611755A1 (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/24/1994 | EP0611569A2 Triglycerides |
| 08/24/1994 | EP0611304A1 Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/24/1994 | EP0611303A1 PREPARATIONS CONTAINING Carboplatin or Lobaplatin FOR ANTI-TUMOUR THERAPY AND/ OR STIMULATING THE HAEMATOPOIETIC SYSTEM |
| 08/24/1994 | EP0611302A1 Methods and compositions for treating allergic reactions |
| 08/24/1994 | EP0506794B1 Novel vitamin d analogues |
| 08/24/1994 | CN1091135A Carbamates of rapamycin |
| 08/24/1994 | CN1091134A Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 08/24/1994 | CN1091132A Novel isoxazolines as antiinflammatory agents |
| 08/24/1994 | CN1091005A Immunopotentiatory agents and physiologically acceptable salts thereof |
| 08/23/1994 | US5340822 Substance P, neurokinin antagonists |
| 08/23/1994 | US5340821 Spirooxathiolane-quinuclidien derivative |
| 08/23/1994 | US5340815 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
| 08/23/1994 | US5340574 Stabilized non-glycosylated recombinant human IL2 in reduced form compositions |
| 08/23/1994 | CA1331672C Peptidic derivatives having a polycyclic nitrogenous structure and process for the preparation thereof |
| 08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
| 08/18/1994 | WO1994018208A1 7,42-bis (o-demethyl) rapamycin |
| 08/18/1994 | WO1994018206A1 Rapamycin derivative process for its preparation and its use |
| 08/18/1994 | WO1994017827A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | WO1994017823A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
| 08/18/1994 | WO1994017816A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | WO1994017796A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
| 08/18/1994 | WO1993008259A3 Inhibitors of dipeptidyl-aminopeptidase type IV |
| 08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1994 | CA2156084A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | CA2155828A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors |
| 08/18/1994 | CA2155554A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2153794A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/17/1994 | EP0610943A1 Pyridinium derivatives useful as PAF antagonists |
| 08/17/1994 | EP0610745A2 Novel aminomethylene derivatives as immunosuppressants |
| 08/17/1994 | EP0610744A1 Sulfonamide aminomethylene derivatives as immunosuppressants |
| 08/17/1994 | EP0610743A1 Novel aminomethylene-peptides as immunosuppressants |
| 08/17/1994 | EP0610655A1 Medicament containing dexpanthenol for topical application |
| 08/17/1994 | EP0610499A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 08/17/1994 | EP0610447A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 08/17/1994 | EP0610445A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 08/17/1994 | EP0610345A1 Combined cellular and immunosuppressive therapies |
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610317A1 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 08/17/1994 | EP0610298A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 08/17/1994 | EP0610257A1 In vitro antibody perfusion of kidney grafts |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0391909B1 Ocular cyclosporin composition |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/17/1994 | CA2115718A1 Novel cyclohexyl alkene compounds, processes for their preparation and pharmaceutical compositions containing them |
| 08/17/1994 | CA2115295A1 Macrocyclic immunomodulators |
| 08/16/1994 | US5338734 Heterocyclic amide derivatives and pharmaceutical use thereof |
| 08/16/1994 | CA1331498C Oligopeptides with cyclic proline-analogous amino acids |
| 08/16/1994 | CA1331443C Saponin adjuvant |
| 08/12/1994 | CA2114183A1 Pyridinium derivatives |
| 08/10/1994 | EP0609905A1 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609739A1 Method of reversing immunosuppression in vaccines |
| 08/10/1994 | EP0609701A1 L-cystein, L-cystine or L-glutamine as a supplementary therapeutic agent for the treatment of immunodeficiency syndrome |
| 08/10/1994 | EP0609606A1 Tucaresol as an immunopotentiatory agent |
| 08/10/1994 | EP0609437A1 Novel sphingoglycolipid and use thereof |
| 08/10/1994 | EP0436620B1 Matrix with immunomodulating activity |
| 08/10/1994 | CN1025612C Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity |
| 08/10/1994 | CA2115224A1 Aminomethylene derivatives as immunosuppressants |
| 08/10/1994 | CA2115222A1 Sulfonamide aminomethylene derivatives as immunosuppressants |
| 08/10/1994 | CA2115221A1 Aminomethylene-peptides as immunosuppressants |
| 08/09/1994 | US5336758 AIDS vaccines |
| 08/09/1994 | US5336686 17 Methylene lactones of steroids |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336489 Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
| 08/09/1994 | CA1331419C Peptides with pharmaceutical activity |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/09/1994 | CA1331345C Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth |
| 08/06/1994 | CA2113913A1 Acetanilide derivatives |
| 08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994017104A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
| 08/04/1994 | WO1994017090A1 2,6-diaminopurine derivatives |
| 08/04/1994 | WO1994017054A1 Oxime derivatives |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016715A1 Selective cell proliferation |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154787A1 Selective cell proliferation |
| 08/04/1994 | CA2154487A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | CA2154358A1 Integrated oligonucleotides |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153688A1 2,6-diaminopurine derivatives |
| 08/04/1994 | CA2132637A1 Icam-related protein |